Top Markets
#1 Threshold Network Threshold Network +65.04%
#2 TENDIES TENDIES +64.30%
#3 Cash Cat Cash Cat +22.24%
#4 OSK OSK +15.86%
#5 Magma Finance Magma Finance +13.64%
#6 Ape and Pepe Ape and Pepe +13.59%
#7 Asteroid Shiba Asteroid Shiba +13.00%
#8 Falcon Finance Falcon Finance +12.81%
#9 Kite Kite +12.56%
#10 龙虾 (Lobster) 龙虾 (Lobster) +11.22%
Coin of the day
Threshold Network Threshold Network
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Windlas Biotech Limited Windlas Biotech Limited

Windlas Biotech Limited

WINDLAS
Classifica tra le azioni #17115
Windlas Biotech Limited functions as a comprehensive contract development and... Windlas Biotech Limited functions as a comprehensive contract development and manufacturing organization (CDMO). Its CDMO offerings span the full product lifecycle, encompassing initial discovery, subsequent development, licensing, and large-scale commercial production of various generic pharmaceutical and nutraceutical items. Through these services, it assists clients in bringing both established and innovative pharmaceutical and nutraceutical products to market, which are then sold under the clients' proprietary brand names. Beyond its CDMO segment, Windlas Biotech also develops and manufactures its own portfolio of domestic trade generics and over-the-counter (OTC) brands, catering to the nutritional, ayurvedic, wellness, and personal care sectors. These in-house products reach consumers via a dual distribution approach: traditional offline channels like distributors, stockists, retail pharmacies, and institutional tenders, alongside a robust online presence through various e-commerce platforms. The company's international reach extends through exports, primarily to markets such as Vietnam, Myanmar, Sri Lanka, Thailand, the Philippines, Cambodia, Fiji, Trinidad & Tobago, and South Africa. Established in 2001, Windlas Biotech is headquartered in Gurugram, India.
Prezzo delle azioni
$12.15
Capitalizzazione di mercato
$257.09M
Variazione (1 giorno)
10.00%
Variazione (1 anno)
9.99%
Paese
IN
Scambia Windlas Biotech Limited (WINDLAS)

Categoria

Healthcare
Margine operativo per Windlas Biotech Limited (WINDLAS)
Margine operativo al 2026 TTM: 0.00%
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Windlas Biotech Limited, il margine operativo attuale (TTM) è 0.00%. Alla fine del 2026, il margine operativo era 0.00%.
Storico del margine operativo per Windlas Biotech Limited da 2026 a 2026
Margine operativo alla fine di ogni anno
Anno Margine Operativo Cambia
Non abbastanza dati per le date fornite.
Margine operativo per aziende simili o concorrenti
Azienda Margine Operativo Differenza del margine operativo Il paese
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
0.00% -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
0.00% -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
0.00% -
JP
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
22.93% -
IN
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
0.00% -
CH
Cos'è l'Margine operativo di un'azienda?
L'Margine operativo è un indicatore chiave per valutare la redditività di un'azienda. Margini operativi più elevati sono generalmente preferibili poiché indicano che l'azienda riesce a vendere i propri prodotti o servizi a un prezzo significativamente superiore rispetto ai costi di produzione. Si calcola dividendo gli utili per i ricavi.